ID: ALA2089302

Max Phase: Preclinical

Molecular Formula: C39H45ClN4O4S

Molecular Weight: 701.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(NS(=O)(=O)CC12CC3CC(C1)CC(NC(=O)C1CC1)(C3)C2)c1ccc(N2CCN(Cc3ccccc3-c3ccc(Cl)cc3)CC2)cc1

Standard InChI:  InChI=1S/C39H45ClN4O4S/c40-33-11-7-29(8-12-33)35-4-2-1-3-32(35)24-43-15-17-44(18-16-43)34-13-9-31(10-14-34)37(46)42-49(47,48)26-38-20-27-19-28(21-38)23-39(22-27,25-38)41-36(45)30-5-6-30/h1-4,7-14,27-28,30H,5-6,15-26H2,(H,41,45)(H,42,46)

Standard InChI Key:  OYGGOERWKSDPFT-UHFFFAOYSA-N

Associated Targets(Human)

Apoptosis regulator Bcl-2/Bcl-2 homologous antagonist/killer 28 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 701.33Molecular Weight (Monoisotopic): 700.2850AlogP: 6.25#Rotatable Bonds: 10
Polar Surface Area: 98.82Molecular Species: ACIDHBA: 6HBD: 2
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.07CX Basic pKa: 8.35CX LogP: 4.65CX LogD: 4.71
Aromatic Rings: 3Heavy Atoms: 49QED Weighted: 0.26Np Likeness Score: -1.17

References

1. Yusuff N, Doré M, Joud C, Visser M, Springer C, Xie X, Herlihy K, Porter D, Touré BB..  (2012)  Lipophilic Isosteres of a π-π Stacking Interaction: New Inhibitors of the Bcl-2-Bak Protein-Protein Interaction.,  (7): [PMID:24900514] [10.1021/ml300095a]

Source